Sun Haoying, Liu Ming
The Affiliated Hospital of Inner Mongolia Medical University Hohhot 010050, Inner Mongolia, China.
Int J Clin Exp Pathol. 2023 May 20;16(5):86-93. eCollection 2023.
This study aims to analyze risk factors for central lymph node metastasis (CLNM) in patients with small papillary thyroid carcinoma (PTC).
The clinicopathologic data of 375 patients with small PTC admitted to the Affiliated Hospital of Inner Mongolia Medical University from January 2017 to December 2020 were analyzed retrospectively. The patients were divided into two groups, namely, CLNM (n = 177) and non-CLNM (n = 198) groups. Relevant data from the two groups were analyzed using the chi-square test, logistic regression analysis, and the receiver operating characteristic (ROC) curve.
The CLNM rate of the 375 patients with small PTC was 47.2%. The chi-square test revealed that CLNM status was correlated with a patient's gender and age as well as tumor size, number of lesions, and invasion of the thyroid capsule (P < 0.05), but not with BRAF gene mutation, Hashimoto's thyroiditis (HT), or nodular goiter. Multivariate analysis indicated significant differences in gender, maximum tumor diameter, multifocality, and thyroid adventitial infiltration between the two groups (all P < 0.05) but no significant difference between the two groups in regard to HT and nodular goiter. The ROC curve suggested that age ≤ 26.5 years and maximum tumor diameter ≥ 0.75 cm were thresholds for increased risk of CLNM.
Lymph node metastasis in the central area of small PTC is associated with multiple factors. Careful examination, analysis, and evaluation of these factors can help in developing accurate individualized treatment strategies.
本研究旨在分析微小乳头状甲状腺癌(PTC)患者中央区淋巴结转移(CLNM)的危险因素。
回顾性分析2017年1月至2020年12月内蒙古医科大学附属医院收治的375例微小PTC患者的临床病理资料。将患者分为两组,即CLNM组(n = 177)和非CLNM组(n = 198)。采用卡方检验、逻辑回归分析和受试者工作特征(ROC)曲线对两组的相关数据进行分析。
375例微小PTC患者的CLNM率为47.2%。卡方检验显示,CLNM状态与患者的性别、年龄以及肿瘤大小、病灶数量和甲状腺被膜侵犯有关(P < 0.05),但与BRAF基因突变、桥本甲状腺炎(HT)或结节性甲状腺肿无关。多因素分析表明,两组在性别、最大肿瘤直径、多灶性和甲状腺外膜浸润方面存在显著差异(均P < 0.05),但在HT和结节性甲状腺肿方面两组无显著差异。ROC曲线提示,年龄≤26.5岁和最大肿瘤直径≥0.75 cm是CLNM风险增加的阈值。
微小PTC中央区淋巴结转移与多种因素有关。仔细检查、分析和评估这些因素有助于制定准确的个体化治疗策略。